379 related articles for article (PubMed ID: 34336642)
1. Construction of Novel lncRNA-miRNA-mRNA Network Associated With Recurrence and Identification of Immune-Related Potential Regulatory Axis in Hepatocellular Carcinoma.
Zhan T; Gao X; Wang G; Li F; Shen J; Lu C; Xu L; Li Y; Zhang J
Front Oncol; 2021; 11():626663. PubMed ID: 34336642
[TBL] [Abstract][Full Text] [Related]
2. Identification of key genes and long non-coding RNA associated ceRNA networks in hepatocellular carcinoma.
Liu J; Li W; Zhang J; Ma Z; Wu X; Tang L
PeerJ; 2019; 7():e8021. PubMed ID: 31695969
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of the MIR4435-2HG/miR-1-3p/MMP9/miR-29-3p/DUXAP8 ceRNA network axis in hepatocellular carcinoma.
Zhang L; Hu S; Chen J; Ma S; Liu F; Liu C; Gao Y
Discov Oncol; 2021 Oct; 12(1):38. PubMed ID: 35201491
[TBL] [Abstract][Full Text] [Related]
4. A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer.
Nie K; Zheng Z; Wen Y; Pan J; Liu Y; Jiang X; Yan Y; Jiang K; Liu P; Xu S; Liu F; Li P
Int Immunopharmacol; 2020 Oct; 87():106845. PubMed ID: 32763781
[TBL] [Abstract][Full Text] [Related]
5. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
[TBL] [Abstract][Full Text] [Related]
6. ASF1B: A Possible Prognostic Marker, Therapeutic Target, and Predictor of Immunotherapy in Male Thyroid Carcinoma.
Qiu W; Wu X; Shi H; Liu B; Li L; Wu W; Lin J
Front Oncol; 2022; 12():678025. PubMed ID: 35174076
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma.
Zheng S; Jiang F; Ge D; Tang J; Chen H; Yang J; Yao Y; Yan J; Qiu J; Yin Z; Ni Y; Zhao L; Chen X; Li H; Yang L
Biomed Pharmacother; 2019 Apr; 112():108695. PubMed ID: 30797154
[TBL] [Abstract][Full Text] [Related]
8. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma.
Zhang T; Cao C; Wu D; Liu L
Tumour Biol; 2016 Feb; 37(2):2379-85. PubMed ID: 26373735
[TBL] [Abstract][Full Text] [Related]
9. ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma.
Ouyang X; Lv L; Zhao Y; Zhang F; Hu Q; Li Z; Zhu D; Li L
Front Oncol; 2021; 11():801506. PubMed ID: 35087760
[TBL] [Abstract][Full Text] [Related]
10. A novel miR-0308-3p revealed by miRNA-seq of HBV-positive hepatocellular carcinoma suppresses cell proliferation and promotes G1/S arrest by targeting double CDK6/Cyclin D1 genes.
Dai X; Huang R; Hu S; Zhou Y; Sun X; Gui P; Yu Z; Zhou P
Cell Biosci; 2020; 10():24. PubMed ID: 32128112
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA SNHG3 promotes the progression of clear cell renal cell carcinoma via regulating BIRC5 expression.
Xu Z; Ye J; Bao P; Wu Q; Xie F; Li P
Transl Cancer Res; 2021 Oct; 10(10):4502-4513. PubMed ID: 35116306
[TBL] [Abstract][Full Text] [Related]
12. LINC00665 Promotes the Progression of Multiple Myeloma by Adsorbing miR-214-3p and Positively Regulating the Expression of PSMD10 and ASF1B.
Wang C; Li M; Wang S; Jiang Z; Liu Y
Onco Targets Ther; 2020; 13():6511-6522. PubMed ID: 32764956
[TBL] [Abstract][Full Text] [Related]
13. A miR-212-3p/SLC6A1 Regulatory Sub-Network for the Prognosis of Hepatocellular Carcinoma.
Zhang DD; Wang WE; Ma YS; Shi Y; Yin J; Liu JB; Yang XL; Xin R; Fu D; Zhang WJ
Cancer Manag Res; 2021; 13():5063-5075. PubMed ID: 34234551
[TBL] [Abstract][Full Text] [Related]
14. Noval ceRNA axis-mediated high expression of
Wang XQ; Li LL; Lou P; Zhang Q; Wang Y
Transl Cancer Res; 2023 Dec; 12(12):3486-3502. PubMed ID: 38193002
[TBL] [Abstract][Full Text] [Related]
15.
Li R; Cui X; Sun W; Yang Z; Shen X; Zhu C
Comb Chem High Throughput Screen; 2023; 26(7):1311-1323. PubMed ID: 35993469
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma.
Hu S; Zhang J; Guo G; Zhang L; Dai J; Gao Y
PLoS One; 2022; 17(4):e0267117. PubMed ID: 35482720
[TBL] [Abstract][Full Text] [Related]
17. [Identification of key molecules in miRNA-mRNA regulatory network associated with high-grade serous ovarian cancer recurrence using bioinformatic analysis].
Zhang P; He M; Zeng Y; Cai X
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jan; 43(1):8-16. PubMed ID: 36856205
[TBL] [Abstract][Full Text] [Related]
18. [Construction and analysis of competitive endogenous RNA regulatory network related to gastric cancer].
Li R; Jiang WJ; Jin SL; Zhao RH; Cao XG; Zong H
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):115-121. PubMed ID: 32135645
[No Abstract] [Full Text] [Related]
19. ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma.
Zhang S; Xu L; Feng J; Tan D; Zhu Y; Hou J; Li W; Lv K; Wang W; Jiang L; Jiao M; Guo H
Front Genet; 2022; 13():842351. PubMed ID: 35360875
[No Abstract] [Full Text] [Related]
20. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
